Janka H U, Ziegler A G, Valsania P, Warram J H, Krolewski A S
Krankenhaus München-Schwabing, Germany.
Diabete Metab. 1989;15(5 Pt 2):333-7.
Although an elevated blood pressure has been proposed as one of the major risk factors for the development and acceleration of diabetic retinopathy, demonstration of an unequivocal association between high blood pressure and retinopathy is lacking. Recent epidemiologic, cross-sectional studies indicated a close relationship between elevated systolic blood pressure and diabetic retinopathy, particularly in NIDDM subjects. In IDDM patients, the association with diastolic blood pressure was more pronounced. In the few prospective studies with sufficient number of individuals and acceptable documentation of retinal changes, in addition to poor metabolic control elevated blood pressure emerged as one of the best predictors of the development of severe deterioration of diabetic eye disease. In the Joslin study the risk of progression to severe forms of diabetic retinopathy increased exponentially with hemoglobin A1c and was dramatically different in patients with diastolic blood pressure below versus above 70 mmHg. It was hypothesized that a very low diastolic blood pressure is associated with some mechanisms which are protective against progression of eye lesions. Treatment and adequate control of hypertension is strongly recommended in all diabetic patients, the optimal level of blood pressure reduction, however, is yet to be determined.
尽管血压升高被认为是糖尿病视网膜病变发生和进展的主要危险因素之一,但高血压与视网膜病变之间明确关联的证据仍不足。近期的流行病学横断面研究表明,收缩压升高与糖尿病视网膜病变密切相关,尤其是在非胰岛素依赖型糖尿病(NIDDM)患者中。在胰岛素依赖型糖尿病(IDDM)患者中,与舒张压的关联更为明显。在少数有足够个体数量且视网膜变化记录可接受的前瞻性研究中,除了代谢控制不佳外,血压升高成为糖尿病眼病严重恶化发展的最佳预测因素之一。在乔斯林研究中,进展为严重形式糖尿病视网膜病变的风险随糖化血红蛋白呈指数增加,舒张压低于70 mmHg与高于70 mmHg的患者之间差异显著。据推测,极低的舒张压与某些预防眼部病变进展的机制有关。强烈建议所有糖尿病患者进行高血压治疗,但血压降低的最佳水平尚待确定。